In the original version of this article (1), Fig. 2C was mislabeled by the compositor during production of the paper and should read: soto-p5/A02 KD = 14.0 nmol/L. Figure 2C has been corrected in the latest online HTML and PDF versions of the article. The publisher regrets the error.
Reference
1.
Hattori
T
,
Maso
L
,
Araki
KY
,
Koide
A
,
Hayman
J
,
Akkapeddi
P
, et al. Creating MHC-restricted neoantigens with covalent inhibitors that can be targeted by immune therapy
. Cancer Discov
2023
;13
:132
–45
.©2023 American Association for Cancer Research
2023
American Association for Cancer Research